Established 2016|Australia's longest-standing research supplier|Trusted by 4,000+ researchers & labs|Batch-tested · Fast AU-wide dispatch
Peptides — Immune & Anti-Microbial

Thymosin α-1

A 28-amino-acid peptide originally isolated from thymic tissue, studied in pre-clinical and clinical immunomodulation research.

Tα1Thymalfasin

Education Hub

Pre-clinical mechanism

Cell-culture studies describe activation of TLR9 and TLR2 signalling in plasmacytoid dendritic cells and modulation of T-cell maturation markers.

Key pre-clinical findings

  • Pre-clinical and clinical literature in chronic hepatitis B as adjunctive therapy (Andreone et al., 1996).

Primary literature

Research and educational use only. This page summarises publicly available pre-clinical literature for educational and scientific reference. It is not medical, clinical, dosing or therapeutic advice. Nothing on this page implies that any VCP Australia product is approved, certified, safe, effective, suitable for a particular purpose, or intended for human or animal consumption.

Research-Use Notice

Products displayed on this website may be intended for laboratory, analytical or research purposes only where applicable. They are not intended to diagnose, treat, cure or prevent any disease. They are not supplied for human or animal consumption unless expressly stated and lawfully permitted. Customers are responsible for understanding and complying with all applicable laws and regulations. Product information is provided for informational purposes only and does not constitute medical advice.